Highlight on advances in nontuberculous mycobacterial disease in North America

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Mirsaeidi, Mehdi ^a   Farshidpour, Maham ^b   Allen, Mary Beth ^c   Ebrahimi, Golnaz ^a   Falkinham, Joseph O ^d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFOXITIN; ETHAMBUTOL; HOST FACTOR; IMIPENEM; RIFAMPICIN; STREPTOMYCIN; TIGECYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC THERAPY; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL ARTHRITIS; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM DETECTION; BONE INFECTION; BRONCHIECTASIS; BROTH DILUTION; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; COMORBIDITY; CYSTIC FIBROSIS; DNA PROBE; DRUG SENSITIVITY; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; GERIATRIC PATIENT; GRAFT RECIPIENT; HEALTH CARE COST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOST RESISTANCE; HUMAN; LYMPHADENITIS; MORTALITY; NONHUMAN; NORTH AMERICA; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RISK FACTOR; SKIN INFECTION; SMEAR; SPECIES IDENTIFICATION; DISEASE PREDISPOSITION; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PATHOGENICITY; TUBERCULOSIS, PULMONARY;

CORYNEBACTERINEAE;

DISEASE SUSCEPTIBILITY; HUMANS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; NORTH AMERICA; TUBERCULOSIS, PULMONARY;

EID: 84918782583     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/919474     Document Type: Review

References (93)

1. Cassidy P. M., Hedberg K., Saulson A., McNelly E., Winthrop K. L., Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clinical Infectious Diseases 2009 49 12 e124 e129 10.1086/648443 2-s2.0-72049104431
2. Mehta M., Marras T. K., Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respiratory Medicine 2011 105 11 1718 1725 10.1016/j.rmed.2011.08.004 2-s2.0-80052963227
3. Adjemian J., Olivier K. N., Seitz A. E., Holland S. M., Prevots D. R., Prevalence of nontuberculous mycobacterial lung disease in U.S. medicare beneficiaries. The American Journal of Respiratory and Critical Care Medicine 2012 185 8 881 886 10.1164/rccm.201111-2016OC 2-s2.0-84860200716
4. Tortoli E., Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clinical Microbiology Reviews 2003 16 2 319 354 10.1128/CMR.16.2.319-354.2003 2-s2.0-0037396976
5. Prevots D. R., Shaw P. A., Strickland D., Jackson L. A., Raebel M. A., Blosky M. A., De Oca R. M., Shea Y. R., Seitz A. E., Holland S. M., Olivier K. N., Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. American Journal of Respiratory and Critical Care Medicine 2010 182 7 970 976 10.1164/rccm.201002-0310OC 2-s2.0-77958175715
6. Kim C. J., Kim N. H., Song K. H., Choe P. G., Kim E. S., Park S. W., Kim H. B., Kim N. J., Kim E. C., Park W. B., Oh M. D., Differentiating rapid- and slow-growing mycobacteria by difference in time to growth detection in liquid media. Diagnostic Microbiology and Infectious Disease 2013 75 1 73 76 10.1016/j.diagmicrobio.2012.09.019 2-s2.0-84870749826
7. Machado D., Ramos J., Couto I., Cadir N., Narciso I., Coelho E., Viegas S., Viveiros M., Assessment of the BD MGIT TBc identification test for the detection of Mycobacterium tuberculosis complex in a network of mycobacteriology laboratories. BioMed Research International 2014 2014 6 398108 10.1155/2014/398108 2-s2.0-84893728808
8. Cayrou C., Turenne C., Behr M. A., Drancourt M., Genotyping of Mycobacterium avium complex organisms using multispacer sequence typing. Microbiology 2010 156 3 687 694 10.1099/mic.0.033522-0 2-s2.0-77749268310
9. Billinger M. E., Olivier K. N., Viboud C., Montes De Oca R., Steiner C., Holland S. M., Prevots D. R., Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerging Infectious Diseases 2009 15 10 1562 1569 10.3201/eid1510.090196 2-s2.0-70349970665
10. van Ingen J., Ferro B. E., Hoefsloot W., Boeree M. J., van Soolingen D., Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence. Expert Review of Anti-Infective Therapy 2013 11 10 1065 1077 10.1586/14787210.2013.830413 2-s2.0-84886910440
11. Griffith D. E., Nontuberculous mycobacterial lung disease. Current Opinion in Infectious Diseases 2010 23 2 185 190 10.1097/QCO.0b013e328336ead6 2-s2.0-77649269175
12. Winthrop K. L., McNelley E., Kendall B., Marshall-Olson A., Morris C., Cassidy M., Saulson A., Hedberg K., Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. The American Journal of Respiratory and Critical Care Medicine 2010 182 7 977 982 10.1164/rccm.201003-0503OC 2-s2.0-77958172574
13. Margaret M., Johnson J. A. O., Nontuberculous mycobacterial pulmonary infections. Journal of Thoracic Disease 2014 6 210 220
14. Adjemian J., Olivier K. N., Seitz A. E., Falkinham J. O. III, Holland S. M., Prevots D. R., Spatial clusters of nontuberculous mycobacterial lung disease in the United States. American Journal of Respiratory and Critical Care Medicine 2012 186 6 553 558 10.1164/rccm.201205-0913OC 2-s2.0-84866393167
15. Mirsaeidi M., Hadid W., Ericsoussi B., Rodgers D., Sadikot R. T., Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. International Journal of Infectious Diseases 2013 17 11 e1000 e1004 10.1016/j.ijid.2013.03.018 2-s2.0-84885374207
16. Marras T. K., Mehta M., Chedore P., May K., Houqani M. A., Jamieson F., Nontuberculous mycobacterial lung infections in Ontario, Canada: Clinical and microbiological characteristics. Lung 2010 188 4 289 299 10.1007/s00408-010-9241-8 2-s2.0-77955555452
17. Damaraju D., Jamieson F., Chedore P., Marras T. K., Isolation of non-tuberculous mycobacteria among patients with pulmonary tuberculosis in Ontario, Canada. International Journal of Tuberculosis and Lung Disease 2013 17 5 676 681 10.5588/ijtld.12.0684 2-s2.0-84876844459
18. Kasperbauer S., Huitt G., Management of extrapulmonary nontuberculous mycobacterial infections. Seminars in Respiratory and Critical Care Medicine 2013 34 1 143 150 10.1055/s-0033-1333576 2-s2.0-84874398212
19. Parker N. P., Scott A. R., Finkelstein M., Tibesar R. J., Lander T. A., Rimell F. L., Sidman J. D., Predicting surgical outcomes in pediatric cervicofacial nontuberculous mycobacterial lymphadenitis. Annals of Otology, Rhinology & Laryngology 2012 121 7 478 484 2-s2.0-84864140631
20. Laquer V., Ta T., Nguyen T., Tan B., Mycobacterium poriferae infection in a psoriasis patient on anti-TNF- α therapy. Dermatology Online Journal 2013 19 9 19609 2-s2.0-84899469229
21. Lembo G., Goldstein E. J. C., Troum O., Mandelbaum B., Successful treatment of mycobacterium terrae complex infection of the knee. Journal of Clinical Rheumatology 2012 18 7 359 362 10.1097/RHU.0b013e31826d1e11 2-s2.0-84867825155
22. Al-Knawya W. B., Garnerb H., Mirsaeidic M., Cawleyd J., Murraye P., Brumblea L., Alvareza S., A descriptive analysis of nontuberculous mycobacterial infections (NTM) of the upper extremity. International Journal of Mycobacteriology 2014 10.1016/j.ijmyco.2014.07.007
23. Mirsaeidi M., Farshidpour M., Ebrahimi G., Aliberti S., Falkinham J. O. III, Management of nontuberculous mycobacterial infection in the elderly. European Journal of Internal Medicine 2014 25 4 356 363 10.1016/j.ejim.2014.03.008 2-s2.0-84899979377
24. Mergenhagen K. A., Olbrych P. M., Mattappallil A., Krajewski M. P., Ott M. C., Effect of azithromycin on anticoagulation-related outcomes in geriatric patients receiving warfarin. Clinical Therapeutics 2013 35 4 425 430 10.1016/j.clinthera.2013.02.012 2-s2.0-84876314790
25. Baciewicz A. M., Chrisman C. R., Finch C. K., Self T. H., Update on rifampin, rifabutin, and rifapentine drug interactions. Current Medical Research and Opinion 2013 29 1 1 12 10.1185/03007995.2012.747952 2-s2.0-84871364478
26. Brode S. K., Jamieson F. B., Ng R., Campitelli M. A., Kwong J. C., Paterson J. M., Li P., Marchand-Austin A., Bombardier C., Marras T. K., Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. Chest 2014 146 3 563 572 10.1378/chest.13-2058
27. Piersimoni C., Scarparo C., Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons. Emerging Infectious Diseases 2009 15 9 1351 1544 10.3201/eid1509.081259 2-s2.0-70249107844
28. Shamriz O., Engelhard D., Rajs A. P., Kaidar-Shwartz H., Casanova J.-L., Averbuch D., Mycobacterium szulgai chronic multifocal osteomyelitis in an adolescent with inherited STAT1 deficiency. Pediatric Infectious Disease Journal 2013 32 12 1345 1347 01.inf.0000437067.43859.4c 2-s2.0-84884383460
29. Garcia D. C., Sandoval-Sus J., Razzaq K., Young L., Vertebral osteomyelitis caused by Mycobacterium abscessus. BMJ Case Reports 2013 009597 10.1136/bcr-2013-009597 2-s2.0-84884271805
30. Longardner K., Allen A., Ramgopal M., Spinal osteomyelitis due to Mycobacterium fortuitum in a former intravenous drug user. BMJ Case Reports 2013 2013 2-s2.0-84895846089 10.1136/bcr-2013-010326
31. Talanow R., Vieweg H., Andresen R., Atypical osteomyelitis caused by mycobacterium chelonae-a multimodal imaging approach. Case Reports in Infectious Diseases 2013 2013 528795
32. Kennedy B. S., Bedard B., Younge M., Tuttle D., Ammerman E., Ricci J., Doniger A. S., Escuyer V. E., Mitchell K., Noble-Wang J. A., O'Connell H. A., Lanier W. A., Katz L. M., Betts R. F., Mercurio M. G., Scott G. A., Lewis M. A., Goldgeier M. H., Outbreak of Mycobacterium chelonae infection associated with tattoo ink. The New England Journal of Medicine 2012 367 11 1020 1024 10.1056/NEJMoa1205114 2-s2.0-84866091996
33. Pham-Huy A., Robinson J. L., Tapiéro B., Bernard C., Daniel S., Dobson S., Déry P., Le Saux N., Embree J., Valiquette L., Quach C., Current trends in nontuberculous mycobacteria infections in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. Paediatrics and Child Health 2010 15 5 276 282 2-s2.0-77954781837
34. Mirsaeidi M., Machado R. F., Garcia J. G. N., Schraufnagel D. E., Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study. PLoS ONE 2014 9 3 e91879 10.1371/journal.pone.0091879 2-s2.0-84897976390
35. Andréjak C., Thomsen V. Ø., Johansen I. S., Riis A., Benfield T. L., Duhaut P., Sørensen H. T., Lescure F.-X., Thomsen R. W., Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. The American Journal of Respiratory and Critical Care Medicine 2010 181 5 514 521 10.1164/rccm.200905-0778OC 2-s2.0-77649148255
36. O'Reilly L. M., Daborn C. J., The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tubercle and Lung Disease 1995 76, supplemet 1 1 46 2-s2.0-0029160978
37. Dega H., Robert J., Bonnafous P., Jarlier V., Grosset J., Activities of several antimicrobials against Mycobacterium ulcerans infection in mice. Antimicrobial Agents and Chemotherapy 2000 44 9 2367 2372 10.1128/AAC.44.9.2367-2372.2000 2-s2.0-0033844507
38. Mirsaeidi M., Personalized medicine approach in mycobacterial disease. International Journal of Mycobacteriology 2012 1 2 59 64 10.1016/j.ijmyco.2012.03.001 2-s2.0-84887213643
39. Keating M. R., Daly J. S., Nontuberculous mycobacterial infections in solid organ transplantation. American Journal of Transplantation 2013 13 supplement 4 77 82 10.1111/ajt.12101 2-s2.0-84874824686
40. Winthrop K. L., Chang E., Yamashita S., Iademarco M. F., LoBue P. A., Nontuberculous mycobacteria infections and anti-tumor necrosis factor- α therapy. Emerging Infectious Diseases 2009 15 10 1556 1561 10.3201/eid1510.090310 2-s2.0-70349970943
41. Chan E. D., Iseman M. D., Underlying host risk factors for nontuberculous mycobacterial lung disease. Seminars in Respiratory and Critical Care Medicine 2013 34 1 110 123 10.1055/s-0033-1333573 2-s2.0-84874397842
42. Leung J. M., Olivier K. N., Nontuberculous mycobacteria: The changing epidemiology and treatment challenges in cystic fibrosis. Current Opinion in Pulmonary Medicine 2013 19 6 662 669 10.1097/MCP.0b013e328365ab33 2-s2.0-84885185531
43. Kartalija M., Ovrutsky A. R., Bryan C. L., Pott G. B., Fantuzzi G., Thomas J., Strand M. J., Bai X., Ramamoorthy P., Rothman M. S., Nagabhushanam V., McDermott M., Levin A. R., Frazer-Abel A., Giclas P. C., Korner J., Iseman M. D., Shapiro L., Chan E. D., Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes. The American Journal of Respiratory and Critical Care Medicine 2013 187 2 197 205 10.1164/rccm.201206-1035OC 2-s2.0-84872535592
44. Chan E. D., Iseman M. D., Older women appear to be more susceptible to nontuberculous mycobacterial lung disease. Gender Medicine 2010 7 1 5 18 10.1016/j.genm.2010.01.005 2-s2.0-77049085307
45. Colombo R. E., Hill S. C., Claypool R. J., Holland S. M., Olivier K. N., Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest 2010 137 3 629 634 10.1378/chest.09-1173 2-s2.0-77949506650
46. Sapkota B. R., Hijikata M., Matsushita I., Tanaka G., Ieki R., Kobayashi N., Toyota E., Nagai H., Kurashima A., Tokunaga K., Keicho N., Association of SLC11A1 (NRAMP1) polymorphisms with pulmonary Mycobacterium avium complex infection. Human Immunology 2012 73 5 529 536 10.1016/j.humimm.2012.02.008 2-s2.0-84860247167
47. Weiss G., Fritsche G., Nairz M., Libby S. J., Fang F. C., Slc11a1 (Nramp1) impairs growth of Salmonella enterica serovar typhimurium in macrophages via stimulation of lipocalin-2 expression. Journal of Leukocyte Biology 2012 92 2 353 359 10.1189/jlb.1111554 2-s2.0-84864768441
48. Zwilling B. S., Kuhn D. E., Wikoff L., Brown D., Lafuse W., Role of iron in Nramp1-mediated inhibition of mycobacterial growth. Infection and Immunity 1999 67 3 1386 1392 2-s2.0-0033008432
49. Dorman S., Subramanian A., Nontuberculous mycobacteria in solid organ transplant recipients. The American Journal of Transplantation 2009 9, supplement 4 S63 S69 10.1111/j.1600-6143.2009.02895.x 2-s2.0-72949112052
50. Piersimoni C., Nontuberculous mycobacteria infection in solid organ transplant recipients. European Journal of Clinical Microbiology and Infectious Diseases 2012 31 4 397 403 10.1007/s10096-011-1329-4 2-s2.0-84862868365
51. Knoll B. M., Kappagoda S., Gill R. R., Goldberg H. J., Boyle K., Baden L. R., Fuhlbrigge A. L., Marty F. M., Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study. Transplant Infectious Disease 2012 14 5 452 460 10.1111/j.1399-3062.2012.00753.x 2-s2.0-84867651872
52. Longworth S. A., Vinnard C., Lee I., Sims K. D., Barton T. D., Blumberg E. A., Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study. Transplant Infectious Disease 2014 16 1 76 83 10.1111/tid.12170 2-s2.0-84893842274
53. Huang H. C., Weigt S. S., Derhovanessian A., Palchevskiy V., Ardehali A., Saggar R., Saggar R., Kubak B., Gregson A., Ross D. J., Lynch J. P. III, Elashoff R., Belperio J. A., Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality. Journal of Heart and Lung Transplantation 2011 30 7 790 798 10.1016/j.healun.2011.02.007 2-s2.0-79959232329
54. Rodman D. M., Polis J. M., Heltshe S. L., Sontag M. K., Chacon C., Rodman R. V., Brayshaw S. J., Huitt G. A., Iseman M. D., Saavedra M. T., Taussig L. M., Wagener J. S., Accurso F. J., Nick J. A., Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 2005 171 6 621 626 10.1164/rccm.200403-404OC 2-s2.0-20144385873
55. Leung J. M., Olivier K. N., Nontuberculous mycobacteria in patients with cystic fibrosis. Seminars in Respiratory and Critical Care Medicine 2013 34 1 124 134 10.1055/s-0033-1333574 2-s2.0-84874397430
56. Aitken M. L., Limaye A., Pottinger P., Whimbey E., Goss C. H., Tonelli M. R., Cangelosi G. A., Ashworth Dirac M., Olivier K. N., Brown-Elliott B. A., McNulty S., Wallace R. J. Jr., Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. The American Journal of Respiratory and Critical Care Medicine 2012 185 2 231 232 10.1164/ajrccm.185.2.231 2-s2.0-84855995836
57. Esther C. R. Jr., Esserman D. A., Gilligan P., Kerr A., Noone P. G., Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. Journal of Cystic Fibrosis 2010 9 2 117 123 10.1016/j.jcf.2009.12.001 2-s2.0-76749097178
58. Winthrop K. L., Baxter R., Liu L., Varley C. D., Curtis J. R., Baddley J. W., McFarland B., Austin D., Radcliffe L., Suhler E. B., Choi D., Rosenbaum J. T., Herrinton L. J., Mycobacterial diseases and antitumour necrosis factor therapy in USA. Annals of the Rheumatic Diseases 2013 72 1 37 42 10.1136/annrheumdis-2011-200690 2-s2.0-84871061278
59. Griffith D. E., Aksamit T., Brown-Elliott B. A., Catanzaro A., Daley C., Gordin F., Holland S. M., Horsburgh R., Huitt G., Iademarco M. F., Iseman M., Olivier K., Ruoss S., Von Reyn C. F., Wallace R. J. Jr., Winthrop K., An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. The American Journal of Respiratory and Critical Care Medicine 2007 175 4 367 416 10.1164/rccm.200604-571ST 2-s2.0-33847050904
60. Wang H. C., Liaw Y. S., Yang P. C., Kuo S. H., Luh K. T., A pseudoepidemic of Mycobacterium chelonae infection caused by contamination of a fibreoptic bronchoscope suction channel. European Respiratory Journal 1995 8 8 1259 1262 10.1183/09031936.95.08081259 2-s2.0-0029086025
61. Arend S. M., Van Soolingen D., Ottenhoff T. H., Diagnosis and treatment of lung infection with nontuberculous mycobacteria. Current Opinion in Pulmonary Medicine 2009 15 3 201 208 10.1097/MCP.0b013e3283292679 2-s2.0-67649236784
62. van Ingen J., Diagnosis of nontuberculous mycobacterial infections. Seminars in Respiratory and Critical Care Medicine 2013 34 1 103 109 10.1055/s-0033-1333569 2-s2.0-84874397685
63. de Bel A., de Geyter D., de Schutter I., Mouton C., Wellemans I., Hanssens L., Schelstraete P., Malfroot A., Pierard D., Sampling and decontamination method for culture of Nontuberculous Mycobacteria in respiratory samples of cystic fibrosis patients. Journal of Clinical Microbiology 2013 51 12 4204 4206 10.1128/JCM.02035-13 2-s2.0-84889854878
64. Chihota V. N., Grant A. D., Fielding K., Ndibongo B., Van Zyl A., Muirhead D., Churchyard G. J., Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting. International Journal of Tuberculosis and Lung Disease 2010 14 8 1024 1031 2-s2.0-77954704762
65. Saleeb P., Olivier K. N., Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients. Current Infectious Disease Reports 2010 12 198 203
66. Park J. S., Choi J.-I., Lim J.-H., Ahn J.-J., Jegal Y., Seo K. W., Ra S. W., Jeon J. B., Lee S. H., Kim S.-R., Jeong J., The combination of real-time PCR and HPLC for the identification of non-tuberculous mycobacteria. Annals of Laboratory Medicine 2013 33 5 349 352 10.3343/alm.2013.33.5.349 2-s2.0-84883776115
67. Jagielski T., Van Ingen J., Rastogi N., Dziadek J., Mazur P. K., Bielecki J., Current methods in the molecular typing of Mycobacterium tuberculosis and other Mycobacteria. BioMed Research International 2014 2014 21 645802 10.1155/2014/645802 2-s2.0-84893421624
68. Jeong J., Kim S.-R., Lee S. H., Lim J.-H., Choi J. I., Park J. S., Chang C. L., Choi J. Y., Richman D. D., Smith D. M., The use of high performance liquid chromatography to speciate and characterize the epidemiology of mycobacteria. Laboratory Medicine 2011 42 10 612 617 10.1309/LMDDEHPSYE6ZDM3C 2-s2.0-81455140016
69. Rogers J. T., Procop G. W., Steelman C. K., Abramowsky C. R., Tuohy M. T., Shehata B. M., Clinical utility of DNA amplification and sequencing to identify a strain of Mycobacterium avium in paraffin-embedded, formalin-fixed biopsies from an immunosuppressed child. Pediatric and Developmental Pathology 2012 15 4 315 317 10.2350/11-07-1061-CR.1 2-s2.0-84868642463
70. Varma-Basil M., Garima K., Pathak R., Dwivedi S. K. D., Narang A., Bhatnagar A., Bose M., Development of a novel pcr restriction analysis of the hsp65 gene as a rapid method to screen for the Mycobacterium tuberculosis complex and nontuberculous mycobacteria in high-burden countries. Journal of Clinical Microbiology 2013 51 4 1165 1170 10.1128/JCM.03067-12 2-s2.0-84875842528
71. Jang M.-A., Koh W.-J., Huh H. J., Kim S.-Y., Jeon K., Ki C.-S., Lee N. Y., Distribution of nontuberculous mycobacteria by multigene sequence-based typing and clinical significance of isolated strains. Journal of Clinical Microbiology 2014 52 4 1207 1212 10.1128/JCM.03053-13 2-s2.0-84897134212
72. Shin A.-R., Lee K.-S., Lee K. I., Shim T. S., Koh W.-J., Jeon H. S., Son Y.-J., Shin S.-J., Kim H.-J., Serodiagnostic potential of Mycobacterium avium MAV2054 and MAV5183 proteins. Clinical and Vaccine Immunology 2013 20 2 295 301 10.1128/CVI.00649-12 2-s2.0-84874857471
73. Somoskovi A., Mester J., Hale Y. M., Parsons L. M., Salfinger M., Laboratory diagnosis of nontuberculous mycobacteria. Clinics in Chest Medicine 2002 23 3 585 597 10.1016/S0272-5231(02)00018-7 2-s2.0-0036739580
74. Tortoli E., Mariottini A., Mazzarelli G., Evaluation of INNO-LiPA MYCOBACTERIA v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification. Journal of Clinical Microbiology 2003 41 9 4418 4420 10.1128/JCM.41.9.4418-4420.2003 2-s2.0-0042420223
75. van Ingen J., Boeree M. J., van Soolingen D., Mouton J. W., Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resistance Updates 2012 15 3 149 161 10.1016/j.drup.2012.04.001 2-s2.0-84862668242
76. Brown-Elliott B. A., Nash K. A., Wallace R. J. Jr., Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clinical Microbiology Reviews 2012 25 3 545 582 10.1128/CMR.05030-11 2-s2.0-84864508047
77. Babady N. E., Hall L., Abbenyi A. T., Eisberner J. J., Brown-Elliott B. A., Pratt C. J., McGlasson M. C., Beierle K. D., Wohlfiel S. L., Deml S. M., Wallace R. J. Jr., Wengenack N. L., Evaluation of Mycobacterium avium complex clarithromycin susceptibility testing using SLOMYCO sensititre panels and JustOne strips. Journal of Clinical Microbiology 2010 48 5 1749 1752 10.1128/JCM.01936-09 2-s2.0-77951783197
78. Cook J. L., Nontuberculous mycobacteria: opportunistic environmental pathogens for predisposed hosts. British Medical Bulletin 2010 96 1 45 59 10.1093/bmb/ldq035 2-s2.0-78649685020
79. Griffith D. E., Aksamit T. R., Therapy of refractory nontuberculous mycobacterial lung disease. Current Opinion in Infectious Diseases 2012 25 2 218 227 10.1097/QCO.0b013e3283511a64 2-s2.0-84858009182
80. Jarand J., Levin A., Zhang L., Huitt G., Mitchell J. D., Daley C. L., Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clinical Infectious Diseases 2011 52 5 565 571 10.1093/cid/ciq237 2-s2.0-79951837354
81. Safdar A., Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis. European Journal of Clinical Microbiology and Infectious Diseases 2012 31 8 1883 1887 10.1007/s10096-011-1516-3 2-s2.0-84866343558
82. Döffinger R., Helbert M. R., Barcenas-Morales G., Yang K., Dupuis S., Ceron-Gutierrez L., Espitia-Pinzon C., Barnes N., Bothamley G., Casanova J.-L., Longhurst H. J., Kumararatne D. S., Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clinical Infectious Diseases 2004 38 1 e10 e14 10.1086/380453 2-s2.0-1542542689
83. Kampmann B., Hemingway C., Stephens A., Davidson R., Goodsall A., Anderson S., Nicol M., Schölvinck E., Relman D., Waddell S., Langford P., Sheehan B., Semple L., Wilkinson K. A., Wilkinson R. J., Ress S., Hibberd M., Levin M., Acquired predisposition to mycobacterial disease due to autoantibodies to IFN- γ The Journal of Clinical Investigation 2005 115 9 2480 2488 10.1172/JCI19316 2-s2.0-24644486557
84. Browne S. K., Zaman R., Sampaio E. P., Jutivorakool K., Rosen L. B., Ding L., Pancholi M. J., Yang L. M., Priel D. L., Uzel G., Freeman A. F., Hayes C. E., Baxter R., Cohen S. H., Holland S. M., Anti-CD20 (rituximab) therapy for anti-IFN- γ autoantibody-associated nontuberculous mycobacterial infection. Blood 2012 119 17 3933 3939 10.1182/blood-2011-12-395707 2-s2.0-84860333126
85. Czaja C. A., Merkel P. A., Chan E. D., Lenz L. L., Wolf M. L., Alam R., Frankel S. K., Fischer A., Gogate S., Perez-Velez C. M., Knight V., Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-gamma autoantibody. Clinical Infectious Diseases 2014 58 e115 e118 10.1093/cid/cit809
86. Hoefsloot W., van Ingen J., de Lange W. C. M., Dekhuijzen P. N. R., Boeree M. J., van Soolingen D., Clinical relevance of Mycobacterium malmoense isolation in the Netherlands. European Respiratory Journal 2009 34 4 926 931 10.1183/09031936.00039009 2-s2.0-70349840697
87. Van Ingen J., Totten S. E., Helstrom N. K., Heifets L. B., Boeree M. J., Daley C. L., In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease. Antimicrobial Agents and Chemotherapy 2012 56 12 6324 6327 10.1128/AAC.01505-12 2-s2.0-84869232612
88. Wallace R. J. Jr., Brown-Elliott B. A., McNulty S., Philley J. V., Killingley J., Wilson R. W., York D. S., Shepherd S., Griffith D. E., Macrolide/azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease. Chest 2014 146 2 276 282 10.1378/chest.13-2538
89. Binder A. M., Adjemian J., Olivier K. N., Rebecca Prevots D., Epidemiology of Nontuberculous Mycobacterial infections and associated chronic Macrolide use among persons with cystic fibrosis. The American Journal of Respiratory and Critical Care Medicine 2013 188 7 807 812 10.1164/rccm.201307-1200OC 2-s2.0-84885183409
90. Wallace R. J. Jr., Dukart G., Brown-Elliott B. A., Griffith D. E., Scerpella E. G., Marshall B., Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections. Journal of Antimicrobial Chemotherapy 2014 69 7 1945 1953
91. Jeon K., Kwon O. J., Nam Y. L., Kim B.-J., Kook Y.-H., Lee S.-H., Young K. P., Chang K. K., Koh W.-J., Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. American Journal of Respiratory and Critical Care Medicine 2009 180 9 896 902 10.1164/rccm.200905-0704OC 2-s2.0-70350432979
92. Leber A., Marras T. K., The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada. European Respiratory Journal 2011 37 5 1158 1165 10.1183/09031936.00055010 2-s2.0-79955656748
93. Collier S. A., Stockman L. J., Hicks L. A., Garrison L. E., Zhou F. J., Beach M. J., Direct healthcare costs of selected diseases primarily or partially transmitted by water. Epidemiology and Infection 2012 140 11 2003 2013 10.1017/S0950268811002858 2-s2.0-84862014504